Want to see TSE:CRRX full AI Analyst Report?
CRRX Stock Chart & Stats
C$3.20
C$0.01(0.30%)
At close: 4:00 PM EDT
C$3.20
C$0.01(0.30%)
Day’s Range― - ―
52-Week RangeC$3.10 - C$4.00
Previous CloseN/A
Volume3.46K
Average Volume (3M)10.35K
Market Cap
C$202.44M
Enterprise ValueC$291.62
Total Cash (Recent Filing)C$10.05M
Total Debt (Recent Filing)C$76.33M
Price to Earnings (P/E)7.4
Beta0.14
Next Earnings
Nov 11, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend Yield2.57%
Share Statistics
EPS (TTM)0.42
Shares Outstanding63,514,038
10 Day Avg. Volume12,498
30 Day Avg. Volume10,346
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)2.19
Price to Sales (P/S)0.65
P/FCF Ratio10.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$4.75Price Target Upside48.44% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.14
Revenue Forecast (FY)C$383.38M
Bulls Say, Bears Say
Bulls Say
Return To ProfitabilityThe return to profitability indicates that CareRx has improved its earnings base after several loss-making years. Positive net income provides greater capacity to fund operations, support capital allocation, and benefit from future volume growth across its institutional pharmacy network.
Strong Cash GenerationSubstantial operating and free cash flow gives CareRx internally generated funding for debt service, efficiency investments, and expansion. Free cash flow equal to roughly 84% of net income also supports the quality of reported earnings over the medium term.
Contracted Bed GrowthAdding approximately 3,000 retirement beds through a long-term agreement should expand recurring prescription volumes and improve network scale. Management expects the business to be accretive over time, reinforcing CareRx’s position in institutional senior-care pharmacy.
Bears Say
Thin Operating MarginsCareRx remains profitable but has limited margin protection, leaving earnings sensitive to cost increases or weaker volumes. Thin operating leverage can restrict the company’s ability to absorb funding changes while still investing in service quality and network growth.
Ontario Funding HeadwindThe Ontario funding change creates a multi-period revenue and earnings drag rather than a one-quarter fluctuation. Recovery depends on ward-room redevelopment and is not expected until late 2027, limiting near-term growth and keeping policy exposure material.
Tighter Liquidity And LeverageLower cash and higher net debt reduce financial flexibility even though leverage remains manageable. With relatively thin margins, further cash demands or weaker earnings could constrain investment capacity and make balance-sheet improvement more dependent on sustained operating cash flow.
CareRx News
CRRX FAQ
What was CareRx’s price range in the past 12 months?
CareRx lowest stock price was C$3.10 and its highest was C$4.00 in the past 12 months.
What is CareRx’s market cap?
CareRx’s market cap is C$202.44M.
When is CareRx’s upcoming earnings report date?
CareRx’s upcoming earnings report date is Nov 11, 2026 which is in 51 days.
How were CareRx’s earnings last quarter?
CareRx released its earnings results on Jul 29, 2026. The company reported C$0.01 earnings per share for the quarter, missing the consensus estimate of C$0.023 by -C$0.013.
Is CareRx overvalued?
According to Wall Street analysts CareRx’s price is currently Undervalued.
Does CareRx pay dividends?
CareRx pays a Quarterly dividend of C$0.022 which represents an annual dividend yield of 2.57%. See more information on CareRx dividends here
What is CareRx’s EPS estimate?
CareRx’s EPS estimate is 0.04.
How many shares outstanding does CareRx have?
CareRx has 63,514,038 shares outstanding.
What happened to CareRx’s price movement after its last earnings report?
CareRx reported an EPS of C$0.01 in its last earnings report, missing expectations of C$0.023. Following the earnings report the stock price went up 3.797%.
Which hedge fund is a major shareholder of CareRx?
Currently, no hedge funds are holding shares in TSE:CRRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CareRx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$4.75 (48.44% Upside)
C$4.75 (48.44% Upside)
Insider Transactions
Bought Shares
Worth C$31.4K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.14%
12-Months-Change
Fundamentals
Return on Equity
2.57%
Trailing 12-Months
Asset Growth
11.38%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
CareRx
CareRx Corporation, operating with its subsidiaries, specializes in delivering tailored pharmaceutical services to Canada's senior demographic. The company manages a vast network of medication dispensing facilities, which are responsible for providing chronic prescriptions and a variety of other advanced clinical pharmacy solutions. Currently, it caters to approximately 50,000 individuals residing in roughly 900 distinct senior and communal living environments, including extended care residences, retirement communities, supportive living facilities, and group homes. Founded in 2001 and based in Toronto, Canada, the corporation rebranded as CareRx Corporation in June 2020, having formerly been known as Centric Health Corporation.
CRRX Stock 12 Month Forecast
Average Price Target
C$4.75
▲(48.44% Upside)
Technical Analysis
Extendicare
―
Nova Leap Health
―
Sienna Senior Living
―
Medical Facilities
―
WELL Health Technologies Corp
―